What's Hot

    Life Risk News Volume 2, Issue 5, May 2023 Out Now!

    12 May 2023

    Editor’s Letter – Volume 2, Issue 5, May 2023

    12 May 2023

    Latest Secondary Market Data Provides More Ammunition for Life Settlement Bulls

    12 May 2023
    Facebook Twitter Instagram
    Instagram LinkedIn Twitter
    Life Risk News
    • Home
    • Features

      Latest Secondary Market Data Provides More Ammunition for Life Settlement Bulls

      12 May 2023

      Latest Cost of Insurance Litigation Provides Little in the Way of Certainty

      12 May 2023

      Roundtable: UK Pension Risk Transfer Consultants

      12 May 2023

      Q&A: Thomas Deinet, Executive Director, Standards Board for Alternative Investments

      12 May 2023

      Life Settlement Market Trends Solid But Investors Should Look Below The Headline Numbers

      12 May 2023
    • Commentary

      Moderation in All Things

      12 May 2023

      “Bet The Under”: Hedge Fund Manager Makes Costly Mistake

      12 May 2023

      What Investment Risks Impact a Life Settlement Fund Manager’s Returns and How Can These Be Mitigated?

      13 April 2023

      Long COVID and Reinfection Risk

      13 April 2023

      The Impacts of Climate Change on Mortality

      8 March 2023
    • Events
    • Magazine
    Life Risk News
    Home»Features»Latest Cost of Insurance Litigation Provides Little in the Way of Certainty

    Latest Cost of Insurance Litigation Provides Little in the Way of Certainty

    Features 12 May 2023Jeffrey DavisBy Jeffrey Davis
    Twitter LinkedIn Email
    Litigation
    Share
    Twitter LinkedIn Email

    Skellig ICAV, a collective investment vehicle from Ireland, along with Gannet Funds and its securities intermediary, Wilmington Trust, have reached a settlement with John Hancock Life Insurance Company of New York in a lawsuit accusing the insurer of unlawfully increasing the cost of insurance on a targeted group of universal life insurance policies.

    The plaintiffs had filed the lawsuit in the U.S. District Court for the Southern District of New York in Manhattan, citing “sudden and massive COI increases” and seeking compensatory and punitive damages, equitable relief, and attorneys’ fees.

    Details of the settlement were not released. The suit was filed in September of 2022.

    According to the filing from March 2022, “the parties hereby stipulate to dismiss this action in its entirety with prejudice, with each Party to bear its own attorney’s fees and costs.” The reference to “with prejudice” means that the plaintiff will not be allowed to bring the same claim to the court again.

    “The settlement terms are confidential, but we’re pleased with the outcome,” plaintiff attorney Khai LeQuang, a partner in the Orange County of law firm Orrick, told Life Risk News.

    Asked if the settlement might influence other existing COI litigation, LeQuang said that would be “unlikely because these agreements tend to be confidential.”

    “I think insurance companies will have to consider that not all policy owners will be satisfied with the economics of class action settlements, and that is a good thing,” he said in response to a question from Life Risk News about a possible broader impact on the life settlement market.

    Representatives from John Hancock were contacted for this story and responded that they “will be in touch if we have a comment.”

    According to the lawsuit, John Hancock increased the cost of insurance on a specific group of its life insurance policies, including policies owned by the plaintiffs.

    Skellig runs a fund that owns a Performance UL policy with a $15m death benefit and argued that John Hancock increased cost-of-insurance rates for that policy and 1,500 others in 2018 but without giving a clear explanation.

    While John Hancock had not disclosed the criteria used to define the targeted group subject to the rate increase, the plaintiffs said it seems to consist of disproportionate numbers of investor-owned policies. By raising the cost of insurance rates without proper justification and only on this targeted group, John Hancock has breached the terms of the plaintiffs’ policies, according to the lawsuit.

    “Notably, in recent years, a handful of life insurance companies have increased cost of insurance rates despite consistent improvements in U.S. mortality over the past several decades,” the lawsuit stated. “These rate increases have prompted numerous lawsuits, all of which, to Plaintiffs’ knowledge, have resulted in the insurance companies paying out millions of dollars in settlements or verdicts. John Hancock itself recently settled a lawsuit concerning its failure to lower cost of insurance rates—despite improved mortality — for over $91 million.”

    The most important factor in life insurance is mortality, and it is widely known in the industry that mortality has improved since John Hancock began issuing Performance UL policies in 2003, the lawsuit states. In fact, new mortality tables would support a decrease in COI rates, but John Hancock increased rates on the plaintiffs’ policies anyway, which goes against the express and implied terms and conditions of the policies.

    The lawsuit noted that industry analysts confirm that mortality has continued to improve. For instance, a report published by Towers Watson in 2016 recommends that life insurance companies assume positive improvements in mortality for every age over 55. Similarly, the lawsuit states, statistics from the Human Mortality Database show increased life expectancy and lower mortality rates for older individuals in the United States between 2010 and 2015, while a Society of Actuaries report on historical population mortality rates indicates continuing improvements in mortality rates every five years from 2000 to 2014.

    Also from the lawsuit: “According to a 2010 report by the Government Accountability Office (GAO), life settlements can be a beneficial option for policyholders with unneeded life insurance, as they can receive more by selling the policy to a third-party investor than surrendering it to the insurer for its cash value. Insurance companies, such as John Hancock, have embraced the life settlement market to sell more insurance, with consumers buying insurance with the comfort of knowing they could sell their policies for fair market value later.

    “However, John Hancock has targeted many of these policies for cost of insurance (COI) increases, forcing policyholders and investors to either pay exorbitant rates to keep their policies or lapse/surrender them, thereby destroying the economic benefit of the policies. A weakened life settlement market would be of particular concern to senior insureds, who stand to lose significant value from any obstacles to selling their policies. Reports indicate that a significant number of senior citizens let their policies lapse or surrender them, with many of them indicating they would have considered selling their policies in the life settlement market had they known about it. Therefore, insurance companies like John Hancock that raise COI rates in contravention of contractual terms are not only hurting policyholders but also the entire life settlement market, including hundreds of thousands of senior consumers.”

    Volume 2 Issue 5 - May 2023
    Share. Twitter LinkedIn Email

    Related Posts

    Latest Secondary Market Data Provides More Ammunition for Life Settlement Bulls

    12 May 2023

    Roundtable: UK Pension Risk Transfer Consultants

    12 May 2023

    Q&A: Thomas Deinet, Executive Director, Standards Board for Alternative Investments

    12 May 2023

    Life Settlement Market Trends Solid But Investors Should Look Below The Headline Numbers

    12 May 2023

    Comments are closed.

    Most Popular

    Latest Secondary Market Data Provides More Ammunition for Life Settlement Bulls

    12 May 2023

    Latest Cost of Insurance Litigation Provides Little in the Way of Certainty

    12 May 2023

    Roundtable: UK Pension Risk Transfer Consultants

    12 May 2023

    Moderation in All Things

    12 May 2023
    Ad

    Your trusted source for capital markets participation in Life Risk

    Twitter Instagram LinkedIn
    Life Risk
    • About Life Risk News
    • Get In Touch
    • Our Team
    • Life Risk News Copyright Notice
    • Life Risk News’ Privacy Policy
    • Sitemap
    Coverage
    • Home
    • Features
    • Events
    • Commentary
    Subscribe

    Type above and press Enter to search. Press Esc to cancel.

    We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept All”, you consent to the use of ALL the cookies. However, you may visit "Cookie Settings" to provide a controlled consent.
    Cookie SettingsAccept All
    Manage consent

    Privacy Overview

    This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
    Necessary
    Always Enabled
    Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
    CookieDurationDescription
    cookielawinfo-checkbox-analytics11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
    cookielawinfo-checkbox-functional11 monthsThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
    cookielawinfo-checkbox-necessary11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
    cookielawinfo-checkbox-others11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
    cookielawinfo-checkbox-performance11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
    viewed_cookie_policy11 monthsThe cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
    Functional
    Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.
    Performance
    Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
    Analytics
    Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
    Advertisement
    Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
    Others
    Other uncategorized cookies are those that are being analyzed and have not been classified into a category as yet.
    SAVE & ACCEPT